PoltechMIBI

Specyfikacja
Okres ważności: 

Kit - 1 year.
After reconstitution and radiolabelling, technetium Tc-99m sestamibi can be used up to 12 hours stored below 25°C

Warunki przechowywania: 

Store in a refrigerator (2°C- 8°C).
During transportation (not longer than 7 days) up to 35°C.
Storage of radiopharmaceuticals should be in accordance with national regulation on radioactive materials.

Postać farmaceutyczna: 

Kit for radiopharmaceutical preparation.
White powder.

Skład jakościowy i ilościowy substancji czynnych: 

1 vial contains
Active substance
[Tetrakis(2-methoxy-2-methylpropyl-1-isocyanide) copper(1+)]tetrafluoroborate   1.00 mg
The radionuclide is not part of the kit.

Wykaz substancji pomocniczych: 

Stannous chloride dihydrate
L-cysteine hydrochloride monohydrate
Sodium citrate dihydrate   
D-mannitol

Rodzaj i zawartość opakowania: 

10 ml glass vials, type I glass (Ph. Eur.) sealed with rubber stopper and an aluminium crimp cap. Vials are packed in cardboard boxes and pack size of 3 or 6 vials are available.
Not all pack sizes may be marketed.

Wskazania do stosowania: 

This medicinal product is for diagnostic use only.
For intravenous injection after radiolabelling with sodium (Tc-99m) pertechnetate solution. PoltechMIBI using scintigraphy is indicated for:
- diagnosis of ischaemic heart disease.
- diagnosis and localisation of myocardial infarction.
- assessment of global ventricular function (first pass technique for determination of ejection fraction and/or regional wall motion).
- diagnosis of malignancy in patients who are suspected of cancer in the breast combined with inconclusive mammography or palpable tumour and negative or inconclusive mammography.
- diagnosis of patients with recurrent
  or persistent hyperparathyroidism.

Załączniki: 
Pliki




	
	
  

Nasza siedziba

Produkty

Certyfikaty